Third Harmonic Bio Inc (NASDAQ: THRD) is 19.51% higher on its value in year-to-date trading and has touched a low of $7.08 and a high of $16.94 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The THRD stock was last observed hovering at around $12.93 in the last trading session, with the day’s gains setting it 0.18%.
Currently trading at $13.11, the stock is -0.14% and -0.86% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.34 million and changing 1.39% at the moment leaves the stock 8.27% off its SMA200. THRD registered 69.16% gain for a year compared to 6-month gain of -3.96%. The firm has a 50-day simple moving average (SMA 50) of $13.2232 and a 200-day simple moving average (SMA200) of $12.108875.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -10.08% loss in the last 1 month and extending the period to 3 months gives it a 11.57%, and is 12.82% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.83% over the week and 9.58% over the month.
Third Harmonic Bio Inc (THRD) has around 30 employees, a market worth around $598.94M and $0.00M in sales. Distance from 52-week low is 85.17% and -22.61% from its 52-week high. The company has generated returns on investments over the last 12 months (-13.18%).
The EPS is expected to shrink by -49.20% this year
117.0 institutions hold shares in Third Harmonic Bio Inc (THRD), with institutional investors hold 101.59% of the company’s shares. The shares outstanding are 40.10M, and float is at 17.43M with Short Float at 17.98%. Institutions hold 92.40% of the Float.
The top institutional shareholder in the company is ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC with over 10.91 million shares valued at $141.8 million. The investor’s holdings represent 26.8961 of the THRD Shares outstanding. As of 2024-06-30, the second largest holder is ORBIMED ADVISORS LLC with 5.78 million shares valued at $75.13 million to account for 14.2498 of the shares outstanding. The other top investors are BVF INC/IL which holds 4.37 million shares representing 10.7653 and valued at over $56.76 million, while ECOR1 CAPITAL, LLC holds 7.8471 of the shares totaling 3.18 million with a market value of $41.37 million.
Third Harmonic Bio Inc (THRD) Insider Activity
The most recent transaction is an insider sale by Conner Edward R., the company’s Chief Medical Officer. SEC filings show that Conner Edward R. sold 2,117 shares of the company’s common stock on Nov 08 ’24 at a price of $15.00 per share for a total of $31755.0. Following the sale, the insider now owns 0.0 shares.
Third Harmonic Bio Inc disclosed in a document filed with the SEC on Oct 29 ’24 that BVF PARTNERS L P/IL (See Explanation of Responses) sold a total of 1,000,000 shares of the company’s common stock. The trade occurred on Oct 29 ’24 and was made at $14.30 per share for $14.3 million. Following the transaction, the insider now directly holds 0.18 million shares of the THRD stock.
Still, SEC filings show that on Oct 28 ’24, Conner Edward R. (Chief Medical Officer) disposed off 2,673 shares at an average price of $15.00 for $40095.0. The insider now directly holds 0 shares of Third Harmonic Bio Inc (THRD).
